Abstract
We studied the clinical effects of LipoPGE1 in 23 patients with sudden deafness who also received methylprednisolone (LipoPGE1 group). Twenty one patients were treated with methylprednisolone without LipoPGE1 (non-LipoPGE1 group).Complete recovery was noted in 10 patients, marked improvement in 4, improvement in 8, and no change in 1 in the LipoPGE1 group. The corresponding figures were 6, 2, 5 and 8 in the non-LipoPGE1 group.The differences were statistically significant. No serious side effects were observed in the LipoPGE1 group.These results suggest that LipoPGE1 therapy combined with steroid is effective in patients with sudden deafness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
